The Nasdaq Biotechnology Index fell by 2%. Among the constituent stocks, Jyong Biotech dropped by 20.95%, BridgeBio Pharma fell by 15.21%, Sionna Therapeutics decreased by 15.12%, Abcellera Biologics declined by 14.98%, and Editas Medicine fell by 14.62%. Gilead Sciences rose by 2.15%, Silence Therapeutics increased by 5.12%, Erasca went up by 5.69%, and Phibro Animal Health surged by 22.02%Wallstreetcn·Feb 5 at 11:56 PMXLV-0.05%ARKG+1.94%
The Nasdaq Biotechnology Index closed down more than 1.7%. Dyne's stock price fell 16.85%, Silence Therapeutics dropped 8.90%, Q32 Bio decreased 8.38%, and Summit Therapeutics Plc. fell 8.13%. Terns Pharmaceuticals rose 6.48%, Wave Life Sciences increased 14.58%, Applied Therapeutics gained 15.32%, and Cartesian Therapeutics climbed 18.08%Wallstreetcn·Dec 9, 2025 at 10:15 PMSLN-4.59%WVE-2.62%
